Wagner to lead new U Institute for Cell, Gene, and Immunotherapy

John E. Wagner Jr., M.D., Headshot

John E. Wagner Jr., M.D.

John E. Wagner Jr., M.D., has been named the founding director of the University of Minnesota Medical School’s new Institute for Cell, Gene, and Immunotherapy (ICGI).

Wagner has played a crucial role in establishing the University’s international clinical leadership in stem cell and umbilical cord blood transplantation. He is a professor of pediatrics, codirector of the Center for Translational Medicine, and program coleader of transplant biology and therapy at the Masonic Cancer Center, University of Minnesota. 

The ICGI aims to accelerate the development and testing of novel cell, gene, and immune-based therapeutics that hold promise in the treatment of life-threatening diseases. 

As director for the ICGI, Wagner will connect the U of M’s work to industry and the community and further establish the University as a leader in this field. 

“This new role is a key part of our strategy to advance interdisciplinary clinical translational research, grow new partnerships with industry, and increase external research funding — all in the pursuit of transforming health and health care,” says Jakub Tolar, M.D., Ph.D., Medical School dean and vice president for clinical affairs. “I am confident that Dr. Wagner’s leadership will allow the University and ICGI to demonstrate growth and success.”  

Published on October 15, 2019